The newest Multiple Sclerosis discovery could be a breakthrough: Lisa Jarvis

Researchers at the University of California at San Francisco have made progress towards a simple diagnostic test for multiple sclerosis (MS). By identifying a unique immune cell signature present years before symptoms appear, they offer hope for early intervention. This breakthrough, potentially applicable to 10% of MS patients, could revolutionize treatment approaches. The test's development underscores the need for early detection in MS and opens avenues for broader research into the disease's early stages, promising significant future impact.

Sign up for your early morning brew of the BizNews Insider to keep you up to speed with the content that matters. The newsletter will land in your inbox at 5:30am weekdays. Register here.

By Lisa Jarvis

We've made significant progress in developing better treatments for multiple sclerosis over the last two decades. Yet the medical community still struggles to diagnose the neurological condition, let alone intervene or study it in its earliest stages, before damage has been done. What we need is a simple test that can definitively tell a patient if they have MS — or are on the road to developing it.

___STEADY_PAYWALL___